The University of Texas Health Science Center at San Antonio
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center at San Antonio sits in the top decile of US sponsors by registered trial count (#94 of 15,742 sponsors by registered trial count).
The University of Texas Health Science Center at San Antonio: 378 sponsored US clinical trials, 77 recruiting.
The University of Texas Health Science Center at San Antonio sponsors 378 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 264 completed. 41 of these trials are in Phase 3-4 (later-stage) and 124 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.
Top-decile sponsor footprint
The University of Texas Health Science Center at San Antonio ranks in the top decile of sponsors by registered trial count (#94 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
264 of 284 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
378 total, page 5 of 8
The Impact of Patient Motivational Dialogue (PMD) on Patient Self-advocacy for Hand Hygiene
NCT04360057
Women's Mammography Study to Improve Comfort During Mammography
NCT02924441
PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria
NCT03168295
High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure
NCT02823626
Stress-Busting Program and QoL, Bio-markers of Immunity/Stress and Cellular Aging
NCT02844478
Ridge Preservation Following Tooth Extraction Using Porcine and Bovine Xenograft Materials
NCT02802319
Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology
NCT02860702
Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)
NCT02865499
Effect of mTOR Inhibition and Other Metabolism Modulating Interventions on the Elderly
NCT02874924
A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer
NCT02753309
Effect of Proton Pump Inhibitors on Gut Microbiota and Systemic Inflammation in Older Adults
NCT02844621
Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer
NCT02716896
Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock
NCT02668432
Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans
NCT02657317
Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects
NCT02538484
Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain
NCT02441660
Metformin for Preventing Frailty in High-risk Older Adults
NCT02570672
A Trial of Treatment for Trauma-Related Nightmares in Active Duty Military Personnel
NCT02506595
ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study
NCT02613897
Skin and Soft Tissue Infection (SSTI) Study
NCT02600871
Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms
NCT02422303
Validity of Patient-Collected Wet Mounts
NCT02641717
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2
NCT02592421
Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods
NCT02418910
Cranial Electrotherapy Stimulation (CES) Therapy
NCT02453347
Impact of Yoga As Complementary Therapy in Patients Undergoing Radical Prostatectomy
NCT02620033
Ridge Preservation Following Tooth Extraction Using Two Mineralized Cancellous Bone Allografts
NCT02515058
A Study of Delivering a Mindfulness App Intervention to Accompany Supportive Care Among Women With Breast Cancer
NCT02601794
Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
NCT02380573
Cognitive-Behavior Therapy for Posttraumatic Headache
NCT02419131
TH-302 in Combination With Bevacizumab for Glioblastoma
NCT02342379
Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream
NCT02918617
S-equol in Women With Triple Negative Breast Cancer
NCT02352025
Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer
NCT02316340
The Role of TLR4 on Lipid-induced Insulin Resistance
NCT02321111
Parent Mentors Using Positive Deviance in Childhood Obesity
NCT02373670
A Euglycemic Insulin Clamp Study in Type 1 Diabetic Patients With Oral Insulin (ORAMED)
NCT02535715
Health4Kids Intervention Trial for Hispanic Families
NCT02343367
The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects
NCT02267317
Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
NCT02324842
Histological Evaluation of Healing Following Ridge Preservation Using a Combined Cortical/Cancellous Mineralized Freeze-Dried Bone Allograft
NCT02275767
Clinical Effectiveness Trial of In-Home Cognitive Processing Therapy for Combat-Related PTSD
NCT02290847
Texas Family Health Patterns: A Study Across Generations
NCT02438254
Improving Transitional Care Experiences in Mental Health
NCT02213198
Prostate Cancer Upgrading Reference Set
NCT02189486
Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy
NCT02299050
Diabetes Effects on Long-Term Implant Survival and Success
NCT02282046
Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)
NCT02127125
Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)
NCT02124759
Clinical and Radiographic Evaluation of Demineralized Freeze-Dried Bone Allograft Versus Platelet Rich Fibrin for the Treatment of Periodontal Intrabony Defects in Humans
NCT02154906
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 45 |
| Phase 3 | 8 |
| Phase 4 | 33 |
Therapeutic Areas
What is open in the The University of Texas Health Science Center at San Antonio pipeline
77 recruiting of 378 indexed (20% open); 264 completed (70%).
Phase mix: 41 late (III/IV) vs 124 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Health Science Center at San Antonio: open-pipeline peers nationwide
Peers matched on 378 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
The University of Texas Health Science Center at San Antonio sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 378 trials (± recruiting share)
- Northwell Health · 370 trials · 22% recruiting
- University of California, Irvine · 368 trials · 20% recruiting
- UNC Lineberger Comprehensive Cancer Center · 366 trials · 22% recruiting
- Roswell Park Cancer Institute · 365 trials · 16% recruiting
Sponsors near 20% open enrollment (± trial volume)
- M.D. Anderson Cancer Center · 20% recruiting · 2,692 trials
- University of Georgia · 20% recruiting · 59 trials
- University of Houston · 20% recruiting · 64 trials
- Florida International University · 20% recruiting · 89 trials
Related
What to do with this The University of Texas Health Science Center at San Antonio page
378 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center at San Antonio or any single study.
- 77 of The University of Texas Health Science Center at San Antonio's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition The University of Texas Health Science Center at San Antonio studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. The University of Texas Health Science Center at San Antonio pipeline card: 378 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.